BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 7941607)

  • 21. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
    Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
    Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
    Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
    Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1994 Apr; 150(8):1233-9. PubMed ID: 8162546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
    Weltman AC; Rose DN
    Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concept in the diagnosis and treatment of childhood pulmonary tuberculosis.
    Singh UK; Suman S
    J Indian Med Assoc; 1996 Oct; 94(10):381-4. PubMed ID: 9141878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy.
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):40-5. PubMed ID: 11263515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.